Browsing by Author Yim, RLH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 13 of 13
TitleAuthor(s)Issue DateViews
 
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics
Journal:Stem Cells and Development
Yim, RLHLee, TYBow, HYCMeij, BLeung, VYLCheung, KMCVavken, PSamartzis, D
2014
37
 
DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin’s Lymphomas
Journal:Frontiers in non-coding RNA
Yim, RLHKwong, YLWong, KYChim, JCS
2012
38
 
Epigenetic inactivation of the MIR129-2 in hematological malignancies
Journal:J Hematol Oncol
Wong, KYYim, RLHKwong, YLLeung, CYHui, PKCheung, FLiang, RHSJin, DYChim, JCS
2013
78
 
Epigenetic inactivation of the MIR34B/C in multiple myeloma
Journal:Blood
Wong, KYYim, RLHSo, CCJin, DYLiang, RChim, CS
2011
232
 
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study
Journal:Cancer
Singh, GHHYim, RLHLee, HKKMak, VLin, SYKho, BYip, SFLau, JSMLi, WIp, HWHwang, YYGChan, SYTTse, EWCAu, WYKumana, CRKwong, YL
2018
107
 
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis
Journal:Annals of Hematology
Singh, GHHIp, HWYim, RLHTang, WFPang, HMHLee, PLeung, GMKLi, JWYTang, KSo, JCCLeung, RYYLi, JPanagiotou, ILam, CCKKwong, YL
2019
83
 
Next-Generation Sequencing with a 54-Gene Panel Identifies Unique Mutational Profile and Prognostic Markers in Chinese Patients with Myelofibrosis
Proceeding/Conference:Blood
Singh, GHHIp, HWYim, RLHTang, TWFPang, HMHLee, PLeung, GMKLi, JWYTang, KSo, JCCLeung, RYYLi, JPanagiotou, ILam, CCKKwong, YL
2017
50
 
Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study
Journal:Cancer
Singh, GHHKumana, CRYim, RLHHwang, YYGChan, SYTYip, SFLee, HKKMak, VLau, JSMChan, CCKho, BWong, RSMLi, WLin, SYLau, CKIp, HWLeung, RYYLam, CCKKwong, YL
2019
53
 
Oral arsenic trioxide, ATRA and ascorbic acid (AAA) maintenance following first complete remission in acute promyelocytic leukaemia – Long-term results and unique prognostic indicators
Journal:Cancer
Singh, GHHYim, RLHTse, EWCKwong, YL
2020
8
 
Oral Arsenic Trioxide, ATRA and Ascorbic Acid (AAA) Maintenance Following First Complete Remission in Acute Promyelocytic Leukemia - Long-Term Data and Unique Prognostic Indicators
Proceeding/Conference:Blood
Singh, GHHYim, RLHKumana, CRKwong, YL
2019
51
 
The safety and efficacy of mesenchymal stem cells for prevention or regeneration of intervertebral disc degeneration: a systematic review
Proceeding/Conference:Global Spine Congress, GSC 2013
Yim, RLHLee, JTYLeung, VYLCheung, KMCVavken, PSamartzis, D
2013
26
 
The safety and efficacy of mesenchymal stem cells for prevention or regeneration of intervertebral disc degeneration: a systematic review
Proceeding/Conference:Annual Meeting of the International Society for the Study of Lumbar Spine, ISSLS 2013
Yim, RLHLee, JTYVavken, PSamartzis, D
2013
 
Whole exome sequencing identifies novel mutations in relapsed or refractory acute promyelocytic leukaemia failing treatment with oral arsenic trioxide
Proceeding/Conference:Congress of the European Hematology Association, EHA 2016
Singh, GHHIp, HWLi, JYim, RLHPanagiotou, GLeung, AYHKwong, YL
2016
76
Showing results 1 to 13 of 13